Mus vs Palau: New cases tested for RR-/MDR-TB (%)
Mus
100.0%
in 2024
Palau
100.0%
in 2024
Mus rank
1st
Palau rank
1st
New cases tested for RR-/MDR-TB (%) over time
- Mus
- Palau
How they compare
Mus currently reports 100.0% against 100.0% in Palau, a difference of 0.0%.
The two have swapped places 4 times across 17 shared years of data; in 2005 it was Palau ahead.
Mus ranks 1st and Palau ranks 1st of 2 regions.
Mus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mus | Palau | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 90.0% | 10.0% | Mus |
| 2010s | 100.0% | 94.4% | 5.6% | Mus |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Mus or Palau?
- Mus, at 100.0% against 100.0% in Palau as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Mus and Palau?
- 0.0%, with Mus ahead.
- How many years of comparable data are there for Mus and Palau?
- 17 years are reported by both, from 2005 to 2024.
- How do Mus and Palau rank globally for new cases tested for rr-/mdr-tb?
- Mus ranks 1st and Palau ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.